|
Home : Ketek KetekKetek - also known as Telithromycin - is an antibiotic medication meant to treat upper respiratory infections such as streptococcus, sinusitis, community acquire pneumonia and bronchitis. Ketek has been on the market since 2004 in the United States. In the past two years, studies have surfaced that bring the Ketek's safety into question. There have been 18 deaths and over 100 cases of liver damage reported in Ketek patients. Click here to read more about the side effects of Ketek. A public safety advisory was issued in 2006 to warn Ketek patients of the risk associated with the drug's use. However, the FDA has not issued a Ketek recall at this time. Controversy continues to unfold regarding Ketek clinical trials and fraudulent studies. In the meantime, patients across the United States have experienced adverse medical events related to the use of the drug and many have filed Ketek lawsuits. On this website LegalView provides numerous resources on Ketek. Follow this link to learn more about Ketek. If you are seeking Ketek legal assistance, please fill out a contact form at any time. When you submit a contact form, a qualified Ketek lawyer will receive your information and contact you. Ketek Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
Want to contact a Washington, DC Ketek lawyer? ...Get a free case evaluation from one of our Washington, DC Ketek lawyers now.
KetekKetek (telithromycin) is a ketolide-class antibiotic manufactured by Sanofi-Aventis. Approved by the FDA in April 2004, the drug has been prescribed over five million times for the treatment of bacterial sinusitis, pneumonia, and chronic bronchitis. The drug has come under fire in recent months upon allegations of adverse Ketek side effects, which include liver damage, liver failure, and death. Other side effects include exacerbation of myasthenia gravis, an autoimmune disorder that causes progressive muscle weakening. A Congressional investigation is attempting to determine why the drug was approved even after a physician was convicted of fraud in clinical trials of Ketek. |




